BFA
SCMP

BlackRock Fund Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

BlackRock Fund Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$18.9M Buy
1,391,369
+131,160
+10% +$1.83M ﹤0.01% 2218
2016
Q3 		$15.5M Buy
1,260,209
+59,723
+5% +$704K ﹤0.01% 2203
2016
Q2 		$13.2M Sell
1,200,486
-429,550
-26% -$4.81M ﹤0.01% 2252
2016
Q1 		$17.8M Buy
1,630,036
+48,420
+3% +$612K ﹤0.01% 2052
2015
Q4 		$27.3M Sell
1,581,616
-36,912
-2% -$662K 0.01% 1858
2015
Q3 		$32.2M Buy
1,618,528
+385,435
+31% +$8.84M 0.01% 1707
2015
Q2 		$20.3M Buy
1,233,093
+169,982
+16% +$2.95M ﹤0.01% 2112
2015
Q1 		$16.5M Buy
1,063,111
+34,414
+3% +$534K ﹤0.01% 2168
2014
Q4 		$14.7M Buy
1,028,697
+74,068
+8% +$782K ﹤0.01% 2236
2014
Q3 		$6.21M Buy
954,629
+1,438
+0.2% +$9.55K ﹤0.01% 2614
2014
Q2 		$6.58M Buy
953,191
+43,105
+5% +$305K ﹤0.01% 2675
2014
Q1 		$6.51M Buy
910,086
+54,308
+6% +$465K ﹤0.01% 2654
2013
Q4 		$8.04M Buy
855,778
+8,747
+1% +$62.4K ﹤0.01% 2520
2013
Q3 		$5.29M Buy
847,031
+119,939
+16% +$749K ﹤0.01% 2775
2013
Q2 		$4.78M Buy
+727,092
New +$5.77M ﹤0.01% 2710

Other funds holding SCMP

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RI
Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Fund Advisors's SCMP Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Sucampo Pharmaceuticals, Inc. (SCMP) stake by 10% in Q4 2016, buying an estimated $1.83M and bringing the position to 1,391,369 shares worth $18.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2218.

BlackRock Fund Advisors first reported a position in SCMP in Q2 2013 and has held it in 15 quarters since. The position peaked at $32.2M in Q3 2015. 165 funds tracked by Wall St. Rank hold SCMP as of Q4 2016.

  • BlackRock Fund Advisors held 1,391,369 shares of Sucampo Pharmaceuticals, Inc. worth $18.9M as of Q4 2016.
  • BlackRock Fund Advisors bought 131,160 Sucampo Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1.83M.
  • Sucampo Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2218 holding.
  • BlackRock Fund Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $32.2M in Q3 2015.
  • 165 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.